Pivotal-Point Tracking Haemonetics (HAE): Medical Technology Specialist for Blood and Plasma Systems Strengthens CSL Partnership
Reading Time: 1 minute
Haemonetics is a leading provider of automated plasmapheresis systems and blood management solutions. The stock jumped by 17.5% to $119.47 on October 8. The reason was the announcement by industry giant CSL Plasma to complete the rollout of the NexSys-PCS devices equipped with Persona-PLUS technology in all US collection centers by the end of 2027. Additionally, the company exceeded expectations in the latest quarter with earnings of $1.14 per share and forecasted revenues of $345.1 million for the second quarter. Haemonetics benefits in two ways...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
